Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 25, 2017

DrugPatentWatch Database Preview

Levocarnitine - Generic Drug Details

« Back to Dashboard

What are the generic sources for levocarnitine and what is the scope of patent protection?

Levocarnitine
is the generic ingredient in three branded drugs marketed by Leadiant Biosci Inc, Lyne, Impax Labs Inc, Luitpold, West-ward Pharms Int, Teva Pharms Usa, and Hi Tech Pharma, and is included in nine NDAs. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Levocarnitine has four patent family members in four countries.

There are four drug master file entries for levocarnitine. Five suppliers are listed for this compound.

Summary for Generic Name: levocarnitine

Tradenames:3
Patents:4
Applicants:7
NDAs:9
Drug Master File Entries: see list4
Suppliers / Packagers: see list5
Bulk Api Vendors: see list52
Clinical Trials: see list4
Patent Applications: see list5,372
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:levocarnitine at DailyMed

Pharmacology for Ingredient: levocarnitine

Ingredient-typeCarnitine
Drug ClassCarnitine Analog
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hi Tech Pharma
LEVOCARNITINE
levocarnitine
SOLUTION;ORAL077399-001Oct 25, 2007AARXNoNo► Subscribe► Subscribe
Luitpold
LEVOCARNITINE
levocarnitine
INJECTABLE;INJECTION075861-001Jun 22, 2001APRXNoNo► Subscribe► Subscribe
Leadiant Biosci Inc
CARNITOR
levocarnitine
TABLET;ORAL018948-001Dec 27, 1985ABRXYesYes► Subscribe► Subscribe
Leadiant Biosci Inc
CARNITOR
levocarnitine
SOLUTION;ORAL019257-001Apr 10, 1986AARXYesYes► Subscribe► Subscribe
Leadiant Biosci Inc
CARNITOR
levocarnitine
INJECTABLE;INJECTION020182-001Dec 16, 1992APRXYesYes6,429,230► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Analyze global market entry opportunities
  • Predict branded drug patent expiration

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot